Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
Details for Australian Patent Application No. 2004314154 (hide)
International Classifications
Event Publications
13 July 2006 PCT application entered the National Phase
PCT publication WO2005/070425 Priority application(s): WO2005/070425
24 March 2011 Application Accepted
Published as AU-B-2004314154
21 July 2011 Standard Patent Sealed
19 January 2012 Extension of Term of Standard Patents
Pierre Fabre Medicament The earliest first regulatory approval date provided by the patentee 22 Feb 2011 For the goods JAVLOR vinflunine ditartrate
2 February 2012 Extension of Term of Standard Patents
Pierre Fabre Medicament Extensions of Term of Standard Patents Extension of Term of a Standard Patent relating to Pharmaceutical Substances Applications Accepted The earliest first regulatory approval date provided by the patentee 22 Feb 2011 For the goods JAVLOR vinflunine ditartrate Address for service in Australia: Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000
23 August 2012 Extension granted
Pierre Fabre Medicament The earliest first regulatory approval date provided by the patentee 22 Feb 2011 For the goods JAVLOR vinflunine ditartrate Extension of Term of patent pursuant to Section 77 expires on 22 Feb 2026
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser